ANDA 75590, held by Epic Pharma LLC. Nabumetone.
As of Nov 15, 2026, ANDA 75590 (Nabumetone), held by Epic Pharma LLC, was first approved by FDA on Feb 25, 2002, with 8 approved supplements and 0 published complete response letters.
| Date | Submission | Status | Documents |
|---|---|---|---|
| Feb 25, 2002 | Original application | Approved |
| Nabumetone500MG · tablet;oral | Nabumetone | Discontinued |
| Nabumetone750MG · tablet;oral | Nabumetone | Discontinued |
| Nov 21, 2024 | Supplement 15Labeling · Standard review | Approved | None posted |
| Apr 28, 2021 | Supplement 14Labeling · Standard review | Approved | None posted |
| May 9, 2016 | Supplement 13Labeling · Standard review | Approved | None posted |
| Nov 8, 2002 | Supplement 1Manufacturing | Approved | None posted |
| Nov 8, 2002 | Supplement 2Manufacturing | Approved | None posted |
| Sep 9, 2002 | Supplement 3Manufacturing | Approved | None posted |
| Sep 9, 2002 | Supplement 4Manufacturing | Approved | None posted |
| Sep 9, 2002 | Supplement 5Manufacturing | Approved | None posted |
| Feb 25, 2002 | Original application | Approved |
Approvals, supplements, products and documents come from FDA's Drugs@FDA data files, refreshed daily; Drugs@FDA lists approved applications only. Complete response letters are FDA's published letters. Drugs@FDA and FDA complete response letters